Article info
PDFShort report
Multiple metastatic clones assessed by an integrative multiomics strategy in clear cell renal carcinoma: a case study
- Correspondence to Dr Frédéric Chalmel, Univ Rennes, Inserm, EHESP, Irset - UMR_S1085, F-35000, Rennes 1 University, Rennes, Bretagne, France; frederic.chalmel{at}inserm.fr
Citation
Multiple metastatic clones assessed by an integrative multiomics strategy in clear cell renal carcinoma: a case study
Publication history
- Received December 17, 2020
- Revised February 17, 2021
- Accepted February 22, 2021
- First published March 25, 2021.
Online issue publication
November 15, 2022
Article Versions
- Previous version (15 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.